To explain the potential reasons for the sensitization to ICI therapy with cuproptosis treatment, we analyzed tumor tissues by serial sections and evaluated the infiltration of CD4+ and CD8+ T cells among different treatment groups using immunohistochemistry. This evidence concerns the gene CD8A and neoplasm.